Directorate of Epidemiology and Diseases Control, Ministry of Health, Rabat, Morocco.
Laboratory of Biostatistics Clinical Research and Epidemiology, Faculty of Medicine and Pharmacy-Mohamed V University, Rabat, Morocco.
PLoS Negl Trop Dis. 2018 Dec 20;12(12):e0006910. doi: 10.1371/journal.pntd.0006910. eCollection 2018 Dec.
Morocco has achieved the goal of leprosy elimination as a public health problem several years ago (less than 1 case/ 10 000 habitant). The aim of this study was to analyze trends of leprosy detection during the last 17 years taking into consideration the implementation of single dose rifampicin chemoprophylaxis (SDRC) started in 2012.
Time series of leprosy cases detected at national level between 2000 and 2017. Variable collected for each year were leprosy per 100000 H, age category, gender, origin, regions, grade of disabilities and clinical forms. The detection time series was assessed by Joinpoint Regression Analysis. Annual percentage changes (APCs) were estimated to identify the years (joinpoint) when significant changes occurred in the trend. We therefore examined trends in leprosy detection according to epidemiological variables.
Joinpoint regression showed a reduction in the detection rate between 2000 and 2017. The APC for the period 2012-2017 (-16.83, 95% CI: -29.2 to -2.3, p <0.05) was more pronounced than that of the previous period 2000-2012 (- 4.68, 95% CI: -7.3 to -2.0, p <0.05); with a significant break in the same joinpoint year SDRC implementation. In stratified analysis, case detection decreased, but not significantly, after the joinpoint years in men, children, multi-bacillary cases, grade 0-1 disabilities, rural and urban cases and in ten regions.
Leprosy detection was declining over years with a significant reduction by 16% per year from 2012 to 2017. SDRC may reduce leprosy detection over the years following its administration.
摩洛哥几年前就实现了将麻风病作为公共卫生问题消除的目标(每 10000 名居民中少于 1 例)。本研究的目的是分析过去 17 年麻风病检测趋势,同时考虑 2012 年开始实施的单剂量利福平化学预防(SDRC)。
2000 年至 2017 年全国范围内检测到的麻风病病例的时间序列。每年收集的变量包括每 100000 名居民中的麻风病例数、年龄组、性别、来源、地区、残疾程度和临床形式。通过 Joinpoint 回归分析评估检测时间序列。估计年百分比变化(APC)以确定趋势中出现显著变化的年份(joinpoint)。因此,我们根据流行病学变量检查了麻风病检测趋势。
Joinpoint 回归显示,2000 年至 2017 年检测率下降。2012-2017 年期间(-16.83,95%CI:-29.2 至-2.3,p<0.05)的 APC 比前一时期 2000-2012 年(-4.68,95%CI:-7.3 至-2.0,p<0.05)更为明显;在 SDRC 实施的同一年份出现了显著的拐点。分层分析显示,在男性、儿童、多菌型病例、0-1 级残疾、农村和城市病例以及十个地区,拐点年后病例检出率虽有所下降,但无统计学意义。
麻风病检测呈下降趋势,2012 年至 2017 年每年下降 16%。SDRC 可能会在其实施后的多年内降低麻风病的检测率。